Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1002/clc.4960150308 http://scihub22266oqcxt.onion/10.1002/clc.4960150308 1551265!ä!1551265 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 245.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Clin+Cardiol 1992 ; 15 (3): 176-80 Nephropedia Template TP {{tp|p=1551265|t=1992. Electrophysiologic and antiarrhythmic effects of magnesium in patients with inducible ventricular tachyarrhythmia |pdf=|usr=}}{{1551265}} gab.com Text Electrophysiologic and antiarrhythmic effects of magnesium in patients with inducible ventricular tachyarrhythmia JO: Clin Cardiol http://www.kidney.de/pget.php?&tw=1&pmid=1551265 #FOAvip Intravenous magnesium is reported to be effective in the treatment of ventricular arrhythmias associated with hypomagnesemia, digitalis toxicity, or prolongation of the QT interval. In most previous reports, magnesium was added to conventional antiarrhythmic drugs that had failed. There are few data on the antiarrhythmic efficacy of magnesium as monotherapy in patients without these associated abnormalities. Ten patients with life-threatening ventricular arrhythmia and inducible ventricular tachyarrhythmia by programmed electrophysiologic testing were treated with intravenous magnesium. Following magnesium infusion, all patients still had inducible ventricular tachyarrhythmia. Moreover, magnesium therapy was not associated with significant changes in ventricular refractory period or in the morphology, cycle length, or hemodynamic response to induced ventricular tachycardia. These data suggest that intravenous magnesium has no significant electrophysiologic or antiarrhythmic effects in patients with life-threatening ventricular arrhythmia and inducible ventricular tachyarrhythmia. Twit Text FOAVip Electrophysiologic and antiarrhythmic effects of magnesium in patients with inducible ventricular tachyarrhythmia ????Clin Cardiol http://www.kidney.de/pget.php?&tw=1&pmid=1551265 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=1551265 #FOAvip English Wikipedia <ref>{{Cite pmid|1551265}}</ref> Electrophysiologic and antiarrhythmic effects of magnesium in patients with inducible ventricular tachyarrhythmia #MMPMID1551265 Hilton TC; Fredman C; Holt DJ; Bjerregaard P; Ira GH Jr; Janosik DL Clin Cardiol 1992[Mar]; 15 (3): 176-80 PMID1551265show ga Intravenous magnesium is reported to be effective in the treatment of ventricular arrhythmias associated with hypomagnesemia, digitalis toxicity, or prolongation of the QT interval. In most previous reports, magnesium was added to conventional antiarrhythmic drugs that had failed. There are few data on the antiarrhythmic efficacy of magnesium as monotherapy in patients without these associated abnormalities. Ten patients with life-threatening ventricular arrhythmia and inducible ventricular tachyarrhythmia by programmed electrophysiologic testing were treated with intravenous magnesium. Following magnesium infusion, all patients still had inducible ventricular tachyarrhythmia. Moreover, magnesium therapy was not associated with significant changes in ventricular refractory period or in the morphology, cycle length, or hemodynamic response to induced ventricular tachycardia. These data suggest that intravenous magnesium has no significant electrophysiologic or antiarrhythmic effects in patients with life-threatening ventricular arrhythmia and inducible ventricular tachyarrhythmia. |Aged[MESH] |Electrophysiology[MESH] |Heart Conduction System/*drug effects[MESH] |Humans[MESH] |Magnesium Sulfate/*pharmacology/therapeutic use[MESH] |Male[MESH] |Middle Aged[MESH] |Tachycardia/*drug therapy/physiopathology[MESH]Electrophysiologic and antiarrhythmic effects of magnesium in patients(epmc).pdf DeepDyve Pubget Overpricing